“showed a trend”

The genomic relatedness G-matrix heatmap ( Figure 2 B) showed a trend consistent with the IBS distance matrix: 55,904 pairs (99.927%) had G-matrix values less than 0.2 (green regions), reflecting moderate genetic relatedness among most individuals, while only 0.004% of pairs had G-matrix values greater than 0.6 (orange regions), indicating very few closely related individuals.

FSP-1 showed a trend toward higher expression on PMMA, while focal adhesion kinase (FAK) transcripts were significantly upregulated in fibroblasts cultured on PMMA compared to titanium.

L-Serine and Tyramine were significantly positively correlated with serum NEFA, and L-Tyrosine showed a trend toward a significant positive correlation with serum NEFA.

[ 23 ] pointed out, in a study on weight prediction and genetic parameters in goats, that genetic correlations between body size traits before and after weaning ranged from 0.09 to 0.99 and showed a trend of gradually increasing with age.

The main effect of MLFs on Lymph counts showed a trend toward reduction during exercise ( P M = 0.090) but was not significant during recovery ( P M = 0.426).

Although their small TGCT subgroup (n = 4) showed a trend towards increased CRIPTO levels, the small sample size limited the possibility of making a definitive interpretation.

mRNA treatment showed a trend toward restoring these proteins, with PDH and ATP5A significantly increasing ( Figure 5 G,H).

Specifically, the differences in the expression of all the aforementioned markers between the Sham group and the IDD group were not constant but showed a trend of dynamically widening over time.

While CB-839 showed a trend towards reduced proliferation, the effect did not reach statistical significance ( Figure 2 D,E).

Although the BSE group showed a trend toward higher systemic exposure compared with SFN, the differences were not statistically significant ( p > 0.05).

Although no statistically significant differences were observed among subgroups, pediatric dentistry specialists showed a trend toward better knowledge of the correct dosage.

In the present case series, patients who received postoperative radiotherapy and chemotherapy showed a trend toward better long-term prognosis and survival. primary urinary cancer neuroendocrine neoplasms rare disease case report short review The author(s) declared that financial support was not received for this work and/or its publication.

Notably, SARM1 protein expression showed a trend consistent with its mRNA expression ( Figure 2 F,G). 3.3.

Microvascular invasion showed a trend toward increased risk, approaching statistical significance.

By days 7 and 14 post-CLI, rats treated with ED-ADSCs showed a trend toward improved blood flow recovery compared with the CLI group, although the difference did not reach statistical significance.

Within IDH-wildtype gliomas, Factor 1 was significant in both external validation cohorts (CGGA1: HR = 1.64, FDR = 4.6 × 10 −6 ; CGGA2: HR = 1.20, FDR = 0.02), though the TCGA IDH-wildtype subgroup showed a trend that did not survive FDR correction (FDR = 0.060).

In contrast, male rats showed a trend toward greater late-phase recovery following whole-blood resuscitation than VBI-1-treated males, although VBI-1-treated males still showed improvement relative to sham controls.

Compared with the LPS-only group, LPS+RvD1 treatment showed a trend toward reduced IL-6 expression and increased IL-10 expression, although these changes did not reach statistical significance ( p = 0.1218 and p = 0.1155, respectively).

In the myeloid compartment, Ly6C/Ly6G profiling showed a trend toward reduced frequencies of Ly6G + cells in paquinimod-treated aged mice ( Figure 4 D).

In our cohort, patients with high CD47 expression within the non-GCB subgroup showed a trend toward lower response rates.

10 (mean: 6.8 cm) showed a trend toward increased root length compared to untreated grain sample no. 5 (mean: 4.9 cm).

However, while DGME showed a trend toward reducing total Th17 cells, it significantly decreased TNF-α + Th17 cells.

118 Additionally, empagliflozin showed a trend of all-cause mortality reduction, albeit not statistically significant due to the limited sample size. 16 The approval of dapagliflozin and empagliflozin for use in patients with CKD and without T2DM provides this population with an effective treatment option, often used in conjunction with RAS inhibitors or as an alternative in patients for whom RAS inhibitors are contraindicated due to hyperkalaemia or hypotension. 117 The results of empagliflozin and dapagliflozin in trials for CKD are summarized in Figure 7 .

It can be seen that with increasing adsorption time, the adsorption capacity of each SnS 2 showed a trend of rapid increase and then tended to equilibrium.

Consistent with the creatinine findings, all intervention groups showed a trend toward attenuating the increase in Kim-1, and a significant reduction was observed in the Licorice (H) + VAN group ( p < 0.05) compared with the VAN group.